Acromegaly is caused by hypersecretion of
growth hormone (GH) and consequently of
insulin-like growth factor-I (IGF-1) due to
pituitary tumor. Other causes, such as increased
growth-hormone releasing hormone (GHRH) production, ectopic GHRH production, and ectopic GH secretion, are rare.
Growth hormone and
IGF-1 play a role in the regulation of bone metabolism, but accurate effect of
growth hormone excess on bone is not fully explained. The issue of osteoarticular manifestations is still very actual, due to development of complications in the majority of patients with
acromegaly. Traditionally,
acromegaly is considered as a cause of secondary
osteoporosis. Nowadays, it is discussed if BMD as predictor of
osteoporotic fractures in acromegalic patient is decreased or even normal. Thus, bone quality remains to be more important in assessment of fracture risk. GH excess leads to increased bone turnover, defined by changes of bone markers. The articular manifestations are frequent clinical complications and may be present as the earliest symptom in a significant proportion of acromegalic patients. Articular manifestations are the main causes of morbidity and immobility of these patients, and they are persistent even after successful treatment. Quick recognition of osteoarticular changes and aiming the
therapy lead to decrease in complication number.